Senator Joseph Lieberman (D-CT) will convene a Senate hearing at Fairfield University to address the public health threat posed by the West Nile virus and other mosquito-borne illnesses. Durland Fish, a Yale expert on insect-borne diseases, will be a...
A treatment for autistic children that was touted by the media and anxious parents as a wonder drug has been shown to have no effect, highlighting the need for controlled studies, according to a Yale psychiatrist. The drug secretin did no better at...
Whether or not a woman’s ovaries are removed during hysterectomy depends partly on where she lives and her surgeon’s experience, according to a Yale School of Medicine study. Removal of healthy ovaries-oophorectomy-is believed to be the most effective...
Yale scientists will initiate cutting edge women’s health research with new grants from the Ethel F. Donaghue Women’s Health Investigator Program at Yale. This year’s recipients of Donaghue Women’s Health Investigator Awards include six Yale faculty...
Herbert S. Chase, M.D., will become Deputy Dean for Education at the Yale School of Medicine in July 2000, Dean David Kessler has announced. Chase succeeds Robert H. Gifford, M.D., who has held the position since 1998. He was Associate Dean for...
Yale researchers have developed a new method for recording the electrical activities within living cells, which could lead to better treatment for diseases like Parkinson’s, and provide clues to how learning occurs. “This new technique offers the hope...
Prevention of bone loss caused by steroid treatments for such diseases as asthma and arthritis will be the topic of a conference given by the Yale School of Medicine. The conference will be held on Friday, Nov. 5 from 8:30 a.m. to 1 p.m. at the New...
A Yale study of complication rates from two radiation implant therapies for prostate cancer shows that the newer therapy, Palladium-103, has fewer long-term side effects than Iodine-125, an older, more commonly prescribed therapy. “While both implants...
Repeated exposure to low-dose amphetamines can cause deficits in cognitive performance that last for several years after the exposure ends, offering insight into potential harmful effects of chronic substance abuse in humans, a Yale study has found. “...
Yale scientists have discovered that the growth of brain cells, which normally ends in adolescence, can be re-stimulated in mature neurons with a molecular mechanism known as Notch signaling. Because Notch signaling also may be involved in the...